• Mashup Score: 0

    Idiopathic pulmonary fibrosis (IPF) currently affects about 100 000 individuals in the US, and millions globally. Patients living with IPF experience disabling symptoms and progressive loss of lung function.1 The 2 treatments approved by the US Food and Drug Administration to treat IPF, nintedanib…

    Tweet Tweets with this article
    • The Future of #Clinical #Trials in #Idiopathic #Pulmonary #Fibrosis https://t.co/CPFMM9D4Pq https://t.co/nNbbPdQRAx

  • Mashup Score: 0
    External Portal | OHSU - 1 year(s) ago

    Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. © 2001-2019 Oregon Health & Science University. OHSU is an equal opportunity affirmative action institution. Notice of Privacy PracticesWeb Browser Accessibility

    Tweet Tweets with this article
    • We are looking for a clinical research compliance specialist to join our #HCM #amyloid #cardiomyopathies team in the rank of a Research Associate. Apply through the OHSU website https://t.co/rIlxoWOaED #Trials #CardioTwitter #MedTwitter